{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T12:51:26Z","timestamp":1785761486509,"version":"3.56.0"},"reference-count":45,"publisher":"BMJ","issue":"4","license":[{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"unspecified","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["World Jnl Ped Surgery"],"accepted":{"date-parts":[[2026,7,13]]},"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:p>Retinoblastoma (Rb) is the most common primary intraocular malignancy in children. Intra-arterial chemotherapy (IAC), often termed ophthalmic artery chemosurgery, has emerged as an important globe-preserving treatment modality for advanced intraocular Rb. We focused on technical delivery, clinical indications, regimen selection, oncological safety, globe salvage, functional preservation and complications. Current evidence indicates that, in appropriately selected patients and experienced centers, IAC can improve local tumor control and globe salvage while reducing systemic toxicity when compared with intravenous chemotherapy. While melphalan remains the backbone chemotherapeutic agent, escalation to topotecan and\/or carboplatin should be guided by tumor burden, vitreous or subretinal seeding, prior treatment response, evidence strength and expected functional potential. Functional preservation should be defined as more than anatomical globe retention; it should include age-appropriate visual acuity or fixation, electroretinography, macular and foveal integrity, avoidance of retinal or choroidal ischemia, amblyopia management, binocular visual development and quality-of-life outcomes. IAC remains associated with ocular and vascular risks, including retinal or choroidal ischemia, cataract formation and ophthalmic artery stenosis or occlusion. Future multicenter prospective studies should use standardized outcome measures, scenario-specific recommendations and molecular monitoring, including aqueous humor cell-free DNA analysis, to refine patient selection and support function-preserving care.<\/jats:p>","DOI":"10.1136\/wjps-2026-001213","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T12:15:14Z","timestamp":1785759314000},"page":"e001213","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Intra-arterial chemotherapy for retinoblastoma: a structured narrative review"],"prefix":"10.1136","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7558-2840","authenticated-orcid":false,"given":"Yan Hong","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daohuan","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caiping","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,8,3]]},"reference":[{"key":"2026080305150504000_9.4.e001213.1","unstructured":"Kaur K , Patel BC . Retinoblastoma. In: StatPearls. Treasure Island (FL): StatPearls Publishing, 2026."},{"key":"2026080305150504000_9.4.e001213.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2009.12.030"},{"key":"2026080305150504000_9.4.e001213.3","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/APO.0000000000000172","article-title":"Unilateral Retinoblastoma Managed With Intravenous Chemotherapy Versus Intra-Arterial Chemotherapy. Outcomes Based on the International Classification of Retinoblastoma","volume":"5","author":"Shields","year":"2016","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"2026080305150504000_9.4.e001213.4","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-018-4406-6","article-title":"Comparison between intravenous chemotherapy and intra-arterial chemotherapy for retinoblastoma: a meta-analysis","volume":"18","author":"Chen","year":"2018","journal-title":"BMC Cancer"},{"key":"2026080305150504000_9.4.e001213.5","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S2352-4642(23)00141-4","article-title":"Intravenous versus super-selected intra-arterial chemotherapy in children with advanced unilateral retinoblastoma: an open-label, multicentre, randomised trial","volume":"7","author":"Wen","year":"2023","journal-title":"Lancet Child Adolesc Health"},{"key":"2026080305150504000_9.4.e001213.6","doi-asserted-by":"publisher","DOI":"10.1136\/neurintsurg-2020-016759"},{"key":"2026080305150504000_9.4.e001213.7","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1001\/jamaophthalmol.2016.0244","article-title":"Intra-arterial Chemotherapy for Retinoblastoma: A Systematic Review","volume":"134","author":"Yousef","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"2026080305150504000_9.4.e001213.8","doi-asserted-by":"publisher","DOI":"10.1136\/neurintsurg-2019-014909"},{"key":"2026080305150504000_9.4.e001213.9","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-021-02610-z"},{"key":"2026080305150504000_9.4.e001213.10","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/archopht.1955.00930010507007","article-title":"Treatment of retinoblastoma by radiation and triethylenemelamine","volume":"53","author":"REESE","year":"1954","journal-title":"AMA Arch Ophthalmol"},{"key":"2026080305150504000_9.4.e001213.11","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-004-0392-6"},{"key":"2026080305150504000_9.4.e001213.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2007.12.014"},{"key":"2026080305150504000_9.4.e001213.13","doi-asserted-by":"publisher","DOI":"10.1136\/jnis-2023-020109"},{"key":"2026080305150504000_9.4.e001213.14","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.822330","article-title":"Treatment of Retinoblastoma: What Is the Latest and What Is the Future","volume":"12","author":"Schaiquevich","year":"2022","journal-title":"Front Oncol"},{"key":"2026080305150504000_9.4.e001213.15","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.30718","article-title":"A multi-institutional feasibility study of intra-arterial chemotherapy in children with retinoblastoma. A Children\u2019s Oncology Group study (COG ARET12P1)","volume":"71","author":"Chintagumpala","year":"2024","journal-title":"Pediatr Blood Cancer"},{"key":"2026080305150504000_9.4.e001213.16","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_866_19"},{"key":"2026080305150504000_9.4.e001213.17","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1177\/1591019919831953","article-title":"Effectiveness of alternative routes of intra-arterial chemotherapy administration for retinoblastoma: Potential for response and complications","volume":"25","author":"Quinn","year":"2019","journal-title":"Interv Neuroradiol"},{"key":"2026080305150504000_9.4.e001213.18","doi-asserted-by":"publisher","DOI":"10.1136\/jnis-2024-022881"},{"key":"2026080305150504000_9.4.e001213.19","doi-asserted-by":"crossref","first-page":"100061","DOI":"10.1016\/j.apjo.2024.100061","article-title":"Update on chemotherapy modalities for retinoblastoma: Progress and challenges","volume":"13","author":"Kritfuangfoo","year":"2024","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"2026080305150504000_9.4.e001213.20","doi-asserted-by":"publisher","DOI":"10.4103\/IJO.IJO_2414_23"},{"key":"2026080305150504000_9.4.e001213.21","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1007\/s12098-024-05095-0","article-title":"Management of Intraocular Retinoblastoma: ICMR Consensus Guidelines","volume":"91","author":"Meel","year":"2024","journal-title":"Indian J Pediatr"},{"key":"2026080305150504000_9.4.e001213.22","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.oret.2025.03.008","article-title":"Ophthalmic Artery Chemosurgery for Retinoblastoma Babies Less than 3 Months Old or under 6-kg Weight","volume":"9","author":"Abramson","year":"2025","journal-title":"Ophthalmol Retina"},{"key":"2026080305150504000_9.4.e001213.23","doi-asserted-by":"publisher","DOI":"10.1136\/bjo-2024-326452"},{"key":"2026080305150504000_9.4.e001213.24","doi-asserted-by":"crossref","unstructured":"Fulton AT , Maniar A , Provenzano A , et al . Comparison of single- versus multi-drug treatment for intra-arterial chemotherapy (IAC) in children with retinoblastoma. Interv Neuroradiol 2025. doi:10.1177\/15910199251324028","DOI":"10.1177\/15910199251324028"},{"key":"2026080305150504000_9.4.e001213.25","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17121955","article-title":"Intra-Arterial Melphalan Chemotherapy for Retinoblastoma in a Developing Nation: Real-World Outcomes and Prognostic Factors","volume":"17","author":"Yousef","year":"2025","journal-title":"Cancers (Basel)"},{"key":"2026080305150504000_9.4.e001213.26","doi-asserted-by":"publisher","DOI":"10.1136\/jnis-2023-020170"},{"key":"2026080305150504000_9.4.e001213.27","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.oret.2025.02.013","article-title":"Intra-arterial Chemotherapy for Retinoblastoma, Outcomes Analysis in 357 Eyes: Thirteen Years of Experience in a Referral Center in Brazil","volume":"9","author":"Teixeira","year":"2025","journal-title":"Ophthalmol Retina"},{"key":"2026080305150504000_9.4.e001213.28","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.rxeng.2025.02.001","article-title":"An updated review of intra-arterial chemotherapy for retinoblastoma","volume":"67","author":"Pai","year":"2025","journal-title":"Radiologia (Engl Ed)"},{"key":"2026080305150504000_9.4.e001213.29","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/IIO.0000000000000591","article-title":"Intra-arterial Chemotherapy for Retinoblastoma: Real-world Experience","volume":"65","author":"Das","year":"2025","journal-title":"Int Ophthalmol Clin"},{"key":"2026080305150504000_9.4.e001213.30","doi-asserted-by":"crossref","DOI":"10.5409\/wjcp.v14.i3.103732","article-title":"Outcomes and adverse events following intra-arterial chemotherapy for retinoblastoma: A single center study in South India","volume":"14","author":"Das","year":"2025","journal-title":"World J Clin Pediatr"},{"key":"2026080305150504000_9.4.e001213.31","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27082466","article-title":"Application of Approved Cisplatin Derivatives in Combination Therapy against Different Cancer Diseases","volume":"27","author":"Tsvetkova","year":"2022","journal-title":"Molecules"},{"key":"2026080305150504000_9.4.e001213.32","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.ajo.2024.09.037","article-title":"Single- Versus Triple-Agent Intra-Arterial Chemotherapy for Retinoblastoma","volume":"269","author":"Alshahrani","year":"2025","journal-title":"Am J Ophthalmol"},{"key":"2026080305150504000_9.4.e001213.33","doi-asserted-by":"crossref","first-page":"916","DOI":"10.4103\/IJO.IJO_2912_24","article-title":"Do\u2019s and Don\u2019ts\" for intraarterial chemotherapy for retinoblastoma- What ophthalmologist and interventional radiologist need to know?","volume":"73","author":"Bhatter","year":"2025","journal-title":"Indian J Ophthalmol"},{"key":"2026080305150504000_9.4.e001213.34","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/s41433-021-01845-y","article-title":"Retinoblastoma and vision","volume":"37","author":"Warda","year":"2023","journal-title":"Eye (Lond)"},{"key":"2026080305150504000_9.4.e001213.35","doi-asserted-by":"crossref","first-page":"207","DOI":"10.17219\/acem\/166664","article-title":"A meta-analysis of the efficacy of intra-arterial chemotherapy for the management of retinoblastoma patients","volume":"33","author":"Yu","year":"2024","journal-title":"Adv Clin Exp Med"},{"key":"2026080305150504000_9.4.e001213.36","doi-asserted-by":"crossref","first-page":"442","DOI":"10.4103\/jcrt.jcrt_2375_24","article-title":"Intra-arterial chemotherapy for unilateral advanced intraocular retinoblastoma: A long-term review of a case series","volume":"21","author":"Li","year":"2025","journal-title":"J Cancer Res Ther"},{"key":"2026080305150504000_9.4.e001213.37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0210647","article-title":"Association of electroretinography with visual outcomes after ophthalmic artery chemosurgery for retinoblastoma in ICRb D and E eyes","volume":"14","author":"Levin","year":"2019","journal-title":"PLoS One"},{"key":"2026080305150504000_9.4.e001213.38","doi-asserted-by":"publisher","DOI":"10.1136\/bjo-2025-328113"},{"key":"2026080305150504000_9.4.e001213.39","doi-asserted-by":"publisher","DOI":"10.1093\/neuros\/nyaa142"},{"key":"2026080305150504000_9.4.e001213.40","doi-asserted-by":"publisher","DOI":"10.1136\/bjo-2022-321723"},{"key":"2026080305150504000_9.4.e001213.41","doi-asserted-by":"publisher","DOI":"10.1001\/archophthalmol.2011.151"},{"key":"2026080305150504000_9.4.e001213.42","doi-asserted-by":"publisher","DOI":"10.3109\/08820538.2014.959188"},{"key":"2026080305150504000_9.4.e001213.43","doi-asserted-by":"crossref","first-page":"527","DOI":"10.4103\/tjo.TJO-D-22-00162","article-title":"Intra-arterial chemotherapy for retinoblastoma: Experience from the pediatric ophthalmology referral center in Malaysia with literature review","volume":"13","author":"Wai","year":"2023","journal-title":"Taiwan J Ophthalmol"},{"key":"2026080305150504000_9.4.e001213.44","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ajo.2023.11.020","article-title":"Aqueous Humor Liquid Biopsy as a Companion Diagnostic for Retinoblastoma: Implications for Diagnosis, Prognosis, and Therapeutic Options: Five Years of Progress","volume":"263","author":"Berry","year":"2024","journal-title":"Am J Ophthalmol"},{"key":"2026080305150504000_9.4.e001213.45","doi-asserted-by":"crossref","DOI":"10.1038\/s41698-025-01255-3","article-title":"Prospective implementation of an aqueous humor liquid biopsy platform informs clinical diagnosis and management of retinoblastoma and other intraocular lesions","volume":"10","author":"Kagami","year":"2026","journal-title":"NPJ Precis Oncol"}],"container-title":["World Journal of Pediatric Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/wjps-2026-001213","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T12:15:18Z","timestamp":1785759318000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjps.bmj.com\/lookup\/doi\/10.1136\/wjps-2026-001213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":45,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,8,3]]},"published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10.1136\/wjps-2026-001213"],"URL":"https:\/\/doi.org\/10.1136\/wjps-2026-001213","relation":{},"ISSN":["2516-5410"],"issn-type":[{"value":"2516-5410","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8]]}}}